Author

Elyssa Ott 1

1 Janssen Research & Development, LLC, Spring House, United States of America

A POOLED SAFETY ANALYSIS FROM THE USTEKINUMAB CROHN?S DISEASE AND PSORIATIC DISEASES PHASE 2 AND 3 CLINICAL TRIAL PROGRAMS

Subrata Ghosh, Bruce E. Sands, Willem de Villiers, Elyssa Ott, Christopher Gasink, Yinghua Lang, Philippe Szapary, Douglas Jacobstein, Brian G. Feagan

Safety of Ustekinumab in Inflammatory Bowel Diseases: Integrated Safety Analysis of Results from Phase 2 and 3 Studies in Crohn's Disease and Ulcerative Colitis

Subrata Ghosh, Bruce E. Sands, Christopher D. O'Brien, Ilia Tikhonov, Yiying Zhou, Sheri Volger, Colleen W. Marano, Elyssa Ott, Christopher Gasink, William Sandborn, Silvio Danese

Item 1 - 2 / 2
1